Filing Flows › Puma Biotechnology (PBYI) › Free cash flow
Puma Biotechnology (PBYI) free cash flow by quarter
Puma Biotechnology's free cash flow was $9.7M in Q3 2025 (third quarter 2025), -31% from Q2 2025. Over the last 3 quarters it ranged from $3.6M (Q1 2025) to $14.1M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $9.7M | -31% | — |
| Q2 2025 | $14.1M | +296% | — |
| Q1 2025 | $3.6M | — | — |
Q3 2025 at a glance
Puma Biotechnology, Q3 2025: revenue $54.5M (-32% year over year), operating margin 17.6%, net earnings $8.8M, operating cash flow $9.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Puma Biotechnology's free cash flow?
Puma Biotechnology's free cash flow was $9.7M in Q3 2025 (third quarter 2025), -31% from Q2 2025.
How has Puma Biotechnology's free cash flow changed?
Over the last 3 quarters it ranged from $3.6M (Q1 2025) to $14.1M (Q2 2025).